Hnrnpa2B1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
HNRNPA2B1 (Heterogeneous Nuclear Ribonucleoprotein A2/B1) is a RNA-binding protein involved in RNA processing, splicing, and transport. Like its paralog HNRNPA1, pathogenic mutations in HNRNPA2B1 cause amyotrophic lateral sclerosis (ALS) and multisystem proteinopathy (MSP). The gene is located on chromosome 7p15.2 and encodes two alternatively spliced isoforms: A2 (341 amino acids) and B1 (353 amino acids). [@martinez2016]
Hnrnpa2B1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
HNRNPA2B1 (Heterogeneous Nuclear Ribonucleoprotein A2/B1) is a RNA-binding protein involved in RNA processing, splicing, and transport. Like its paralog HNRNPA1, pathogenic mutations in HNRNPA2B1 cause amyotrophic lateral sclerosis (ALS) and multisystem proteinopathy (MSP). The gene is located on chromosome 7p15.2 and encodes two alternatively spliced isoforms: A2 (341 amino acids) and B1 (353 amino acids). [@martinez2016]
Gene Information
Function
HNRNPA2B1 contains two RNA recognition motifs (RRMs) and a glycine-rich low-complexity domain similar to HNRNPA1. Key functions include:
Alternative splicing regulation: HNRNPA2B1 regulates splicing of numerous pre-mRNAs, particularly those involved in neuronal development and synaptic function.
mRNA transport: The protein facilitates cytoplasmic transport of specific mRNAs.
Telomere maintenance: HNRNPA2B1 interacts with telomerase and contributes to telomere length regulation.
Stress granule formation: Like HNRNPA1, HNRNPA2B1 localizes to stress granules under cellular stress conditions.
Phase separation: The low-complexity domain promotes liquid-liquid phase separation, forming membraneless organelles including stress granules and nuclear speckles.
The A2 and B1 isoforms differ by inclusion of 12 amino acids in the N-terminal region of B1, with both isoforms performing overlapping but distinct functions.
Disease Associations
Amyotrophic Lateral Sclerosis (ALS)
Dominant mutations in HNRNPA2B1 cause familial ALS. The D262V mutation (in the low-complexity domain) has been extensively characterized and:
Alters phase separation properties of the protein
Promotes formation of cytoplasmic inclusions
Causes altered stress granule dynamics
Leads to [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology in affected [neurons](/entities/neurons)
Patients present with typical ALS phenotype including progressive muscle weakness, spasticity, and bulbar dysfunction.
Multisystem Proteinopathy (MSP)
HNRNPA2B1 mutations can cause MSP with features including:
Inclusion body myopathy
Paget disease of bone
Frontotemporal dementia
Variable penetrance and phenotype
Asthma and Autoimmunity
Interestingly, common variants in HNRNPA2B1 have been associated with increased risk of asthma and certain autoimmune disorders, suggesting broader roles in immune regulation.
Expression
HNRNPA2B1 is ubiquitously expressed with high levels in:
Expression is detected in both neuronal and non-neuronal tissues.
Key Publications
Kim HJ, et al. (2013). Mutations in prion-like domains in hnRNPA1 and hnRNPA2B1 cause ALS. Nature. 495(7442):467-473. PMID: 23455423(https://pubmed.ncbi.nlm.nih.gov/23455423/)
Martinez FJ, et al. (2016). The RNA-binding protein HNRNPA2B1 regulates alternative splicing and disease phenotypes. Nat Neurosci. 19(1):40-53. PMID: 26642042(https://pubmed.ncbi.nlm.nih.gov/26642042/)
The study of Hnrnpa2B1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
Kim HJ, Kim NC, Wang YD, et al, Mutations in prion-like domains in hnRNPA1 and hnRNPA2B1 cause ALS (2013)
Martinez FJ, Pratt GA, Van Nostrand EL, et al, The RNA-binding protein HNRNPA2B1 regulates alternative splicing (2016)
Bampton A, Gittings LM, Fratta P, et al, The role of hnRNPs in ALS (2020)
Related Hypotheses
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
[Axonal RNA Transport Reconstitution](/hypothesis/h-8196b893) — <span style="color:#ffd54f;font-weight:600">0.45</span> · Target: HNRNPA2B1